Daiwa Securities Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1K | Hold |
304
| – | – | ﹤0.01% | 1279 |
|
2025
Q1 | $2K | Hold |
304
| – | – | ﹤0.01% | 1193 |
|
2024
Q4 | $4K | Hold |
304
| – | – | ﹤0.01% | 1177 |
|
2024
Q3 | $6K | Hold |
304
| – | – | ﹤0.01% | 1161 |
|
2024
Q2 | $7K | Hold |
304
| – | – | ﹤0.01% | 1173 |
|
2024
Q1 | $8K | Hold |
304
| – | – | ﹤0.01% | 1174 |
|
2023
Q4 | $9K | Hold |
304
| – | – | ﹤0.01% | 1167 |
|
2023
Q3 | $6K | Hold |
304
| – | – | ﹤0.01% | 1140 |
|
2023
Q2 | $6K | Hold |
304
| – | – | ﹤0.01% | 1162 |
|
2023
Q1 | $5K | Hold |
304
| – | – | ﹤0.01% | 1148 |
|
2022
Q4 | $6K | Buy |
304
+86
| +39% | +$1.7K | ﹤0.01% | 1138 |
|
2022
Q3 | $3K | Hold |
218
| – | – | ﹤0.01% | 1195 |
|
2022
Q2 | $3K | Hold |
218
| – | – | ﹤0.01% | 1197 |
|
2022
Q1 | $3K | Hold |
218
| – | – | ﹤0.01% | 1218 |
|
2021
Q4 | $5K | Hold |
218
| – | – | ﹤0.01% | 1193 |
|
2021
Q3 | $7K | Buy |
218
+98
| +82% | +$3.15K | ﹤0.01% | 1154 |
|
2021
Q2 | $5K | Hold |
120
| – | – | ﹤0.01% | 1072 |
|
2021
Q1 | $5K | Buy |
120
+16
| +15% | +$667 | ﹤0.01% | 1077 |
|
2020
Q4 | $6K | Sell |
104
-210
| -67% | -$12.1K | ﹤0.01% | 1048 |
|
2020
Q3 | $7K | Buy |
314
+30
| +11% | +$669 | ﹤0.01% | 1059 |
|
2020
Q2 | $4K | Hold |
284
| – | – | ﹤0.01% | 1108 |
|
2020
Q1 | $4K | Hold |
284
| – | – | ﹤0.01% | 1109 |
|
2019
Q4 | $6K | Sell |
284
-37
| -12% | -$782 | ﹤0.01% | 1085 |
|
2019
Q3 | $4K | Buy |
321
+45
| +16% | +$561 | ﹤0.01% | 1081 |
|
2019
Q2 | $4K | Hold |
276
| – | – | ﹤0.01% | 1100 |
|
2019
Q1 | $5K | Sell |
276
-124
| -31% | -$2.25K | ﹤0.01% | 1069 |
|
2018
Q4 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 1031 |
|